Skip to main content
Clinical Trials/NL-OMON31451
NL-OMON31451
Completed
Not Applicable

High dose adenosine in acute myocardial infarction study - Hammer 2

Medisch Spectrum Twente0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
acute myocardial infarction
Sponsor
Medisch Spectrum Twente
Enrollment
80
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with acute myocardial infarction with clinical indication for primary PCI.
  • Symptoms of myocardial ischemia less then 6 hours (12 hours in case of anterior infarction with persistent complaints).

Exclusion Criteria

  • history of myocardial infarction
  • history of heart surgery
  • obstructive lungdisease
  • second degree AV\-block.
  • pregnant women
  • contra\-indication for MRI
  • impossibility to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials